Package 68071-3928-9

Brand: bupropion hydrochloride xl

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68071-3928-9
Digits Only 6807139289
Product NDC 68071-3928
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-3928-9)

Marketing

Marketing Status
Marketed Since 2025-12-08
Brand bupropion hydrochloride xl
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45789ea6-b123-a72c-e063-6394a90a0feb", "openfda": {"upc": ["0368071392890"], "unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["45789ff4-af5d-96b0-e063-6394a90a0644"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68071-3928-9)", "package_ndc": "68071-3928-9", "marketing_start_date": "20251208"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "68071-3928_45789ea6-b123-a72c-e063-6394a90a0feb", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68071-3928", "generic_name": "Bupropion Hydrochloride", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20170614", "listing_expiration_date": "20261231"}